OSTX
OS Therapies Incorporated
NYSE MKT: OSTX · HEALTHCARE · BIOTECHNOLOGY
$1.70
+4.29% today
Updated 2026-04-30
Market cap
$77.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.98
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
OS Therapies Incorporated (OSTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-2.41B | $-4.40M | $-3.79M | $-3.01M | $-7.28M | $-14.24B |
| Capital expenditures | $2.01M | $11934.00 | $0.00 | $0.00 | $0.00 | $466423.00 |
| Depreciation | $67000.00 | $805.00 | $805.00 | $4220.00 | $2780.00 | — |
| Stock-based comp | — | — | — | $0.00 | $268300.00 | $4.27B |
| Free cash flow | $-2.42B | $-4.41M | $-3.79M | $-3.01M | $-7.28M | $-14.24B |
| Investing cash flow | $158.29M | $200473.00 | $230881.00 | $1145.00 | — | — |
| Financing cash flow | $3.48B | $3.05M | $3.65M | $2.87M | $12.78M | — |
| Dividends paid | — | — | — | — | $31.25M | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |